We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

86 hedge funds and large institutions have $85M invested in Xeris Biopharma Holdings in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

150% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 14

86% more capital invested

Capital invested by funds: $45.8M → $85M (+$39.3M)

28% more funds holding

Funds holding: 67 → 86 (+19)

22.83% more ownership

Funds ownership: 62.51% → 85.34% (+23%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $685K

Holders
86
Holders Change
+19
Holders Change %
+28.36%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
35
Reduced
14
Closed
10
Calls
–
Puts
$685K
Net Calls
-$685K
Net Calls Change
-$684K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$9.22M
2
SM
Sabby Management
Florida
+$3.78M
3
Invesco
Invesco
Georgia
+$3.48M
4
SC
Sessa Capital
New York
+$3.27M
5
Millennium Management
Millennium Management
New York
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$1.95M
2
HP
Hound Partners
New York
-$1.64M
3
Renaissance Technologies
Renaissance Technologies
New York
-$984K
4
DM
Deerfield Management
New York
-$887K
5
Blackstone Inc
Blackstone Inc
New York
-$762K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Sessa Capital
New York
$11.1M +$3.27M +940,000 +29%
DM
2
Deerfield Management
New York
$8.46M -$887K -254,740 -7%
BlackRock
3
BlackRock
New York
$7.49M +$1.67M +478,430 +20%
JP Morgan Chase
4
JP Morgan Chase
New York
$7.07M +$9.22M +2,648,064 +31,084%
RG
5
Redmile Group
California
$6.38M -$1.95M -560,000 -19%
ACH
6
ArrowMark Colorado Holdings
Colorado
$6.02M -$276K -79,294 -3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.76M +$1.66M +475,407 +28%
Invesco
8
Invesco
Georgia
$5.33M +$3.48M +1,000,000 +100%
SM
9
Sabby Management
Florida
$2.89M +$3.78M +1,086,031 New
AGM
10
Alpine Global Management
New York
$2.66M +$1.72M +494,683 +98%
State Street
11
State Street
Massachusetts
$1.65M +$269K +77,367 +14%
Millennium Management
12
Millennium Management
New York
$1.34M +$1.76M +504,243 New
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$1.33M +$66.7K +19,163 +4%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.29M -$13.4K -3,850 -0.8%
PM
15
Prosight Management
Texas
$1.12M +$1.46M +419,469 New
Northern Trust
16
Northern Trust
Illinois
$1.09M +$39.4K +11,304 +3%
MIM
17
Monashee Investment Management
Massachusetts
$931K +$1.22M +350,000 New
GIM
18
Granahan Investment Management
Massachusetts
$905K +$1.19M +340,403 New
Federated Hermes
19
Federated Hermes
Pennsylvania
$798K – – –
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$798K +$1.04M +300,000 New
DAM
21
Deltec Asset Management
New York
$684K +$895K +257,132 New
EIM
22
Essex Investment Management
Massachusetts
$680K +$890K +255,530 New
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$618K +$809K +232,410 New
PPA
24
Parametric Portfolio Associates
Washington
$608K +$538K +154,598 +209%
BCM
25
Bridgeway Capital Management
Texas
$580K +$348K +100,000 +85%
1
2 3 4

XERS Hedge Fund Activity: Q2 2020 in Review

86 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q2 2020, worth a combined $85M — up 86% from $45.8M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XERS positions and 10 closed out — a net gain of 19 holders — while 35 added to existing stakes and 14 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $9.22M. The largest seller was Redmile Group, cutting an estimated $1.95M.

  • 86 institutional investors held Xeris Biopharma Holdings (XERS) as of Q2 2020, up from 67 in Q1 2020.
  • Funds reported $85M of Xeris Biopharma Holdings stock for Q2 2020, up 86% quarter-over-quarter.
  • 29 funds opened new Xeris Biopharma Holdings positions in Q2 2020 and 10 closed out, a net change of +19 holders.
  • The largest Xeris Biopharma Holdings buyer in Q2 2020 was JP Morgan Chase, an estimated $9.22M added.
  • The largest Xeris Biopharma Holdings seller in Q2 2020 was Redmile Group, an estimated $1.95M sold.

Based on aggregated 13F filings for Q2 2020.